|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| o-Chlorostyrene | CAS 2039-87-4 | ||
| ClC6H4CH=CH2 | RTECS WL4160000 | ||
|
Synonyms & Trade Names 2-Chlorostyrene, ortho-Chlorostyrene, 1-Chloro-2-ethenylbenzene |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 50 ppm (285 mg/m3) ST 75 ppm (428 mg/m3) | ||
| OSHA PEL�: none | |||
| IDLH N.D. | Conversion 1 ppm = 5.67 mg/m3 | ||
|
Physical Description Colorless liquid. |
|||
|
MW: 138.6 |
BP: 372°F |
FRZ: -82°F |
Sol: Insoluble |
|
VP(77°F): 0.96 mmHg |
IP: ? |
|
Sp.Gr: 1.10 |
|
Fl.P: 138°F |
UEL: ? |
LEL: ? |
|
| Class II Combustible Liquid: Fl.P. at or above 100�F and below 140�F. | |||
|
Incompatibilities & Reactivities None reported |
|||
|
Measurement Methods None available |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash Breathing: Respiratory support Swallow: Medical attention immediately |
| Respirator Recommendations To be added later | |
| Exposure Routes inhalation, ingestion, skin and/or eye contact | |
| Symptoms In animals: irritation eyes, skin; hematuria (blood in the urine), proteinuria, acidosis; enlarged liver, jaundice | |
|
Target Organs
Eyes, skin, liver, kidneys, central nervous system, peripheral nervous system |
|
| See also: INTRODUCTION |